Five, seven or ten? No – it’s not a trendy store for juniors… it is a real-life anti-estrogen treatment dilemma facing oncologists and their post-menopausal, ER+, early-stage, breast cancer patients. Standard of care is to take anti-estrogen treatment for at least the first 5 years after diagnosis to help prevent hormone-receptor positive breast cancer recurrences. […]
The world’s best-known breast cancer experts weigh in on issues related to ER+ early stage breast cancer – Part 1
In a consensus report published last week, Endocrine therapy and related issues in hormone receptor‑positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG), the BCTEG addressed four gaps in current guidance for oncologists related to the most common form of breast cancer, estrogen receptor positive (ER+) early stage breast […]
US Breast Cancer Survivors, You’re Not the Only Ones Left Hot and Tired Due to Treatment
BACKGROUND Researchers in the UK analyzed information provided directly by 625 early breast cancer survivors or through electronic patient health records to measure the type and level of the unmet physical and psychosocial needs. An unmet need generally refers to care or help you require but don’t get, for any number of reasons. In the […]
Support During Trying Times
Women diagnosed with breast cancer are left in an emotionally vulnerable position. Hearing the news that you have been diagnosed with breast cancer is not easy to deal with. The words “breast cancer” can be jarring and you may feel alone in your battle. Upon receiving this news it is important for you to find […]
Medical oncologists provide the scoop on treating pre-menopausal women with anti-estrogen therapy
So what are the experts saying about anti-estrogen therapy for pre-menopausal patients diagnosed with breast cancer? Late last year, three dynamic oncologists from the University of Wisconsin, Madison – Amye Tevaarwerk, MD; Kari Wisinski, MD; and Ruth O’Regan, MD – collaborated to publish a review about the history and current state of anti-estrogen treatment. for […]